Export 156 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A. Gomez-Ramos, Picher, A. J., García, E., Garrido, P., Hernández, F., Soriano, E., and Avila, J., Validation of Suspected Somatic Single Nucleotide Variations in the Brain of Alzheimer's Disease Patients., J Alzheimers Dis, vol. 56, no. 3, pp. 977-990, 2017.
C. Gómez, Juan-Cruz, C., Poza, J., Ruiz-Gómez, S. J., Gomez-Pilar, J., Núñez, P., García, M., Fernández, A., and Hornero, R., Alterations of Effective Connectivity Patterns in Mild Cognitive Impairment: An MEG Study., J Alzheimers Dis, vol. 65, no. 3, pp. 843-854, 2018.
G. Gomez, Beason-Held, L. L., Bilgel, M., An, Y., Wong, D., Studenski, S., Ferrucci, L., and Resnick, S. M., Metabolic Syndrome and Amyloid Accumulation in the Aging Brain., J Alzheimers Dis, vol. 65, no. 2, pp. 629-639, 2018.
J. J. Gomar, Conejero-Goldberg, C., Davies, P., and Goldberg, T. E., Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1085-97, 2016.
M. Golzari-Sorkheh, Weaver, D. F., and Reed, M. A., COVID-19 as a Risk Factor for Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 1, pp. 1-23, 2023.
E. L. Goldwaser, Acharya, N. K., Sarkar, A., Godsey, G., and Nagele, R. G., Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease., J Alzheimers Dis, vol. 54, no. 2, pp. 445-56, 2016.
H. L. Golden, Clark, C. N., Nicholas, J. M., Cohen, M. H., Slattery, C. F., Paterson, R. W., Foulkes, A. J. M., Schott, J. M., Mummery, C. J., Crutch, S. J., and Warren, J. D., Music Perception in Dementia., J Alzheimers Dis, vol. 55, no. 3, pp. 933-949, 2017.
T. E. Golde, Schneider, L. S., and Koo, E. H., Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift., Neuron, vol. 69, no. 2, pp. 203-13, 2011.
J. Godin, Armstrong, J. J., Rockwood, K., and Andrew, M. K., Dynamics of Frailty and Cognition After Age 50: Why It Matters that Cognitive Decline is Mostly Seen in Old Age., J Alzheimers Dis, vol. 58, no. 1, pp. 231-242, 2017.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders., J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
T. Glozman, Solomon, J., Pestilli, F., and Guibas, L., Shape-Attributes of Brain Structures as Biomarkers for Alzheimer's Disease., J Alzheimers Dis, vol. 56, no. 1, pp. 287-295, 2017.
H. Glonnegger, Beyle, A., Cerff, B., Gräber, S., Csoti, I., Berg, D., and Liepelt-Scarfone, I., The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease., J Alzheimers Dis, vol. 53, no. 4, pp. 1475-84, 2016.
C. E. Gleason, Fischer, B. L., N Dowling, M., Setchell, K. D. R., Atwood, C. S., Carlsson, C. M., and Asthana, S., Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 47, no. 4, pp. 1009-19, 2015.
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker., J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
L. GjØra, Strand, B. Heine, Bergh, S., Borza, T., Brækhus, A., Engedal, K., Johannessen, A., Kvello-Alme, M., Krokstad, S., Livingston, G., Matthews, F. E., Myrstad, C., Skjellegrind, H., Thingstad, P., Aakhus, E., Aam, S., and Selbæk, G., Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study., J Alzheimers Dis, vol. 79, no. 3, pp. 1213-1226, 2021.
D. A. Gimbel, Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., and Strittmatter, S. M., Memory impairment in transgenic Alzheimer mice requires cellular prion protein., J Neurosci, vol. 30, no. 18, pp. 6367-74, 2010.
J. F. - M. Gilmartin-Thomas, McNeil, J., Powell, A., Malone, D. T., Wolfe, R., Larson, I. C., O'Reilly, C. L., Kirkpatrick, C. M., Kipen, E., Petrovich, T., and J Bell, S., Impact of a Virtual Dementia Experience on Medical and Pharmacy Students' Knowledge and Attitudes Toward People with Dementia: A Controlled Study., J Alzheimers Dis, vol. 62, no. 2, pp. 867-876, 2018.
S. Gill, Mouches, P., Hu, S., Rajashekar, D., MacMaster, F. P., Smith, E. E., Forkert, N. D., and Ismail, Z., Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data., J Alzheimers Dis, vol. 75, no. 1, pp. 277-288, 2020.
T. Gilbert, Roche, S., Blond, E., Bar, J. - Y., Drai, J., Cuerq, C., Haution-Bitker, M., Ecochard, R., and Bonnefoy, M., Association between Peripheral Leptin and Adiponectin Levels and Cognitive Decline in Patients with Neurocognitive Disorders ≥65 Years., J Alzheimers Dis, vol. 66, no. 3, pp. 1255-1264, 2018.
M. José Gil, Manzano, M. Sagrario, Cuadrado, M. Luz, Fernández, C., Góméz, E., Matesanz, C., Calero, M., and Rábano, A., Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features., J Alzheimers Dis, vol. 63, no. 3, pp. 1109-1117, 2018.
R. Gil and Arroyo-Anlló, E. M., Alzheimer's Disease and Face Masks in Times of COVID-19., J Alzheimers Dis, vol. 79, no. 1, pp. 9-14, 2021.
L. M. Giil, Vedeler, C. A., Kristoffersen, E. K., Nordrehaug, J. Erik, Heidecke, H., Dechend, R., Schulze-Forster, K., Muller, D. N., von Goetze, V. S., Cabral-Marques, O., Riemekasten, G., Vogelsang, P., Nygaard, S., Lund, A., and Aarsland, D., Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function., J Alzheimers Dis, vol. 59, no. 3, pp. 929-939, 2017.
L. Melvaer Giil, Midttun, Ø., Refsum, H., Ulvik, A., Advani, iv, R., A Smith, D., and Ueland, P. Magne, Kynurenine Pathway Metabolites in Alzheimer's Disease., J Alzheimers Dis, vol. 60, no. 2, pp. 495-504, 2017.
L. M. Giil, Aarsland, D., Hellton, K., Lund, A., Heidecke, H., Schulze-Forster, K., Riemekasten, G., Vik-Mo, A. Osland, Kristoffersen, E. K., Vedeler, C. A., and Nordrehaug, J. Erik, Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study., J Alzheimers Dis, vol. 64, no. 3, pp. 761-774, 2018.
V. Giannouli, Stamovlasis, D., and Tsolaki, M., Exploring the Role of Cognitive Factors in a New Instrument for Elders' Financial Capacity Assessment., J Alzheimers Dis, vol. 62, no. 4, pp. 1579-1594, 2018.